Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy

Krista C. J. Wink, Jose S. A. Belderbos, Edith M. T. Dieleman, Maddalena Rossi, Coen R. N. Rasch, Ronald A. M. Damhuis, Ruud M. A. Houben, Esther G. C. Troost

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)453-459
JournalRadiotherapy and Oncology
Volume118
Issue number3
DOIs
Publication statusPublished - Mar 2016

Keywords

  • Metformin
  • NSCLC
  • Diabetes
  • Chemotherapy
  • Radiotherapy

Cite this

Wink, K. C. J., Belderbos, J. S. A., Dieleman, E. M. T., Rossi, M., Rasch, C. R. N., Damhuis, R. A. M., Houben, R. M. A., & Troost, E. G. C. (2016). Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy. Radiotherapy and Oncology, 118(3), 453-459. https://doi.org/10.1016/j.radonc.2016.01.012